Boehringer Ingelheim News
Pharmaceutical news of Boehringer Ingelheim GmbH in Germany
Boehringer Ingelheim`s diabetes pipeline continues to advance as the Company announces conclusion of robust Phase III pivotal trials programme for linagliptin
Ingelheim/Germany, 28 September 2009 - Following the release of linagliptin Phase II data earlier this year, Boehringer Ingelheim has now announced the conclusion of the linagliptin pivotal Phase III clinical trials.
- Login or register to post comments
- Read more
- 404 reads
- Feed: Boehringer Ingelheim RSS-Newsfeed
- Original article
Boehringer Ingelheim RSS-Newsfeed
RSS newsfeed of Boehringer Ingelheim GmbH in Germany
- Login or register to post comments
- 246 reads
- Feed items
- Link to site
